ASYMCHEM (06821) Updates Articles of Association After Share Repurchase and New H-Share Allotment

Bulletin Express03-13 21:01

Hong Kong, 13 Mar 2026 – Asymchem Laboratories (Tianjin) Co., Ltd. (ASYMCHEM, 06821) has proposed specific amendments to its Articles of Association to reflect recent capital changes arising from (1) the repurchase and cancellation of restricted A shares granted under the 2025 A-share incentive scheme and (2) the issue and allotment of new H shares to the trustee of its H-share restricted share scheme.

Key amendments and data impact:

1. Registered capital • Article 6 will be updated to RMB360.78 million, up from RMB360.59 million.

2. Share count and structure (Article 21) • Total ordinary shares will rise to 360.78 million. • A-share count adjusts to 332.95 million, representing 92.28 % of total capital (previously 333.04 million, 92.36 %). • H-share count increases to 27.83 million, or 7.72 % of total capital (previously 27.55 million, 7.64 %).

3. Approval process • The amendments require shareholder approval by special resolutions at the forthcoming general meeting. • Effectiveness is conditional on separate endorsement of the Repurchase and Cancellation of restricted A shares under the 2025 scheme.

Other provisions of the Articles remain unchanged. A circular detailing the proposals will be posted on the websites of HKEX and ASYMCHEM in due course.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment